Related references
Note: Only part of the references are listed.Combination urate-lowering therapy in the treatment of gout: What is the evidence?
Fernando Perez-Ruiz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors
Yanqiu Hu et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Design, synthesis and bioevaluation of 3-oxo-6-aryl-2,3-dihydropyridazine-4-carbohydrazide derivatives as novel xanthine oxidase inhibitors
Lichao Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii
Privita Verma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles
Itrat Fatima et al.
BIOORGANIC CHEMISTRY (2018)
Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor
Wenqing Cai et al.
MOLECULES (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
An in-depth view of potential dual effect of thymol in inhibiting xanthine oxidase activity: Electrochemical measurements in combination with four way PARAFAC analysis and molecular docking insights
Saleheh Abbasi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Molecular Docking Studies on Isocytosine Analogues as Xanthine Oxidase Inhibitors
Subhajit Roy et al.
DRUG RESEARCH (2018)
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor
Manroopraj Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer
Pankaj Kumar Singh et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout
Xiansheng Zhang et al.
MEDICINAL CHEMISTRY (2017)
Development of N-hydroxycinnamamide-based HDAC inhibitors with improved HDAC inhibitory activity and in vitro antitumor activity
Jie Zang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
Fernando Perez-Ruiz et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor
He Tian et al.
MOLECULES (2016)
The discovery and evaluation of diaryl ether heterocyclic sulfonamides as URAT1 inhibitors for the treatment of gout
R. Ian Storer et al.
MEDCHEMCOMM (2016)
Urate Handling in the Human Body
David Hyndman et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Mechanism of high affinity inhibition of the human urate transporter URAT1
Philip K. Tan et al.
SCIENTIFIC REPORTS (2016)
Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors
Jeong Uk Song et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors
Rengarajan Kavitha et al.
BIOSYSTEMS (2015)
Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors
Shaolei Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Improving cardiovascular and renal outcomes in gout: what should we target?
Pascal Richette et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Cost-effectiveness of febuxostat in chronic gout
Stephen M. Beard et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Beneficial Effect of Rutin on Oxonate-Induced Hyperuricemia and Renal Dysfunction in Mice
Yu-Sheng Chen et al.
PHARMACOLOGY (2013)
The History and Future of Probenecid
Nathan Robbins et al.
CARDIOVASCULAR TOXICOLOGY (2012)
Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice
Qing-Hua Hu et al.
EUROPEAN JOURNAL OF NUTRITION (2012)
Emerging therapies for gout
Jasvinder A. Singh
EXPERT OPINION ON EMERGING DRUGS (2012)
Combined chemical feature-based assessment and Bayesian model studies to identify potential inhibitors for Factor Xa
Meganathan Chandrasekaran et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors
Kunal Nepali et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study
Vidula Bhole et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Chronic gout: epidemiology, disease progression, treatment and disease burden
Richard A. Brook et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors
Shaojie Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Exploring quantitative structure-activity relationship studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants
Indrani Mitra et al.
MOLECULAR SIMULATION (2010)
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
Sitna Halevy et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A three-dimensional model of human organic anion transporter 1 - Aromatic amino acids required for substrate transport
Jennifer L. Perry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
6-(N-benzoylamino)purine as a novel and potent inhibitor of xanthine oxidase:: Inhibition mechanism and molecular modeling studies
H Tamta et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2005)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Molecular identification of a renal urate-anion exchanger that regulates blood urate levels
A Enomoto et al.
NATURE (2002)
2-Alkyloxyalkylthiohypoxanthines as new potent inhibitors of xanthine oxidase
G Biagi et al.
FARMACO (2001)
Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors
S Ishibuchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
